XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Significant Balance of Accounts Receivable The Company has not experienced any loss on its deposits of cash and cash equivalents. Included in current assets are significant balances of accounts receivable as follows:

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

Falikang — Related party

 

 

42

%

 

 

65

%

AstraZeneca

 

 

33

%

 

 

16

%